Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
about
European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm SocietyIndividual patient data network meta-analysis of mortality effects of implantable cardiac devicesFibrosis: a structural modulator of sinoatrial node physiology and dysfunctionA combined anatomic and electrophysiologic substrate based approach for sudden cardiac death risk stratification2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theAssessing the outcomes of implantable cardioverter defibrillator treatment in a real world setting: results from hospital record dataRadio-frequency ablation as primary management of well-tolerated sustained monomorphic ventricular tachycardia in patients with structural heart disease and left ventricular ejection fraction over 30%.Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials.Risk stratification for sudden cardiac death: current status and challenges for the futureEffectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: a systematic review and meta-analysis.An ECG index of myocardial scar enhances prediction of defibrillator shocks: an analysis of the Sudden Cardiac Death in Heart Failure TrialHuman sinoatrial node structure: 3D microanatomy of sinoatrial conduction pathways.Wearable defibrillator use in heart failure (WIF): results of a prospective registryTools for risk stratification of sudden cardiac death: a review of the literature in different patient populationsMode of death on Chagas heart disease: comparison with other etiologies. a subanalysis of the REMADHE prospective trial.Impact of shocks on mortality in patients with ischemic or dilated cardiomyopathy and defibrillators implanted for primary prevention.Protein biomarkers identify patients unlikely to benefit from primary prevention implantable cardioverter defibrillators: findings from the Prospective Observational Study of Implantable Cardioverter Defibrillators (PROSE-ICD).β1-Adrenergic blocker bisoprolol reverses down-regulated ion channels in sinoatrial node of heart failure rats.SCD-HeFT: Use of R-R interval statistics for long-term risk stratification for arrhythmic sudden cardiac deathSudden cardiac death risk prediction: comment on "Risk factor and prediction modeling for sudden cardiac death in women with coronary artery disease".Electrocardiographic Measures and Prediction of Cardiovascular and Noncardiovascular Death in CKD.Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-AnalysisThe spectrum of epidemiology underlying sudden cardiac death.Overview of implantable cardioverter defibrillator and cardiac resynchronisation therapy in heart failure management.The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results.Early therapy following myocardial infarction: arguments for and against implantable cardioverter-defibrillators.From lead management to implanted patient management: indications to lead extraction in pacemaker and cardioverter-defibrillator systems.ICD's near end of life: risk versus benefit- a review.Deactivation of implantable cardioverter-defibrillators at end of life.Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.Management of ventricular arrhythmias in structural heart disease.Most Heart Failure Patients Die from Pump Failure: Implications for Therapy.European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society.The evolution and benefit of device therapy in patients listed for heart transplant.Arrhythmic risk stratification in heart failure: Time for the next step?Clinical risk profile score predicts all cause mortality but not implantable cardioverter defibrillator intervention rate in a large unselected cohort of patients with congestive heart failure.How robust are clinical trials in heart failure?Cause-of-death analysis in patients with cardiac resynchronization therapy with or without a defibrillator: a systematic review and proportional meta-analysis.The importance of tricuspid regurgitation and right ventricular overload in ICD/CRT recipients: beside the left, beyond the left.Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
P2860
Q26796261-3A17CF97-E493-407F-86D0-EA2497126F9FQ26798319-C36AA95D-074F-4322-84FF-FFC6FA7E93F6Q26828018-FF47486D-D406-4F83-874F-2AF4DD324A53Q27015902-AA2419C7-9B6C-494B-A1AF-916E16BBA465Q28087002-4EBC7A66-E7B2-41AE-89B2-425D8B980B62Q30599499-14CB17B3-8E3A-4460-9424-0B7B4FB93F1DQ33163845-88806387-B211-45CB-AA01-505362B47151Q33770849-C03ABC8D-9A57-418B-9FB1-8F687C869606Q33827123-D2C01E50-9519-4193-901F-914B15A62E95Q34237260-55EF77B4-F1E1-42A6-A800-0619B4230675Q34441831-1F078197-43E8-4CCF-8E8C-D50A7D3FCAC4Q34507987-9B875E1F-64CC-4069-9B95-F8C49CE6A09DQ34509631-5841C199-269C-48A1-AEFB-D70B3066D116Q34541818-E0F56B15-6C18-492D-BBCC-A8351E9B6E39Q34702442-CB0FF0D7-E034-40D8-8CB6-06434D95D559Q34723139-E406C444-71FD-4B90-B758-56B0B7B38DB7Q35107904-49BDB852-F314-429F-98B3-9FD8D84B5F57Q35963962-E85A87A4-E686-4F2B-B4EE-D1D6A0DDA3AFQ36094817-75FD0B30-5B00-479F-B930-00EE34229D94Q36102415-F9EA6E2B-0BAD-4224-A06C-8E25586F2894Q36514900-BC90B5C7-7EFC-48E2-8D4E-488E76DDE30EQ36836290-7078CC22-2F21-4FAF-83BA-10EE015D912EQ37057557-BE34B356-3CB9-41DA-AE44-DA3AE7DFDB8FQ37121219-9F652880-15C6-4AF8-A42C-C1EB74EE0DA9Q37312814-7B51B000-B616-4279-8FA6-33278DB3C4E5Q37749822-3FA897E5-2A60-4F91-8EDD-1BC313B27B25Q37850450-487C3C5C-16DC-4615-B0E1-ECDF0ADFCBDBQ37973285-2533D69B-3639-4C83-94AC-079434981F96Q38158220-63DD0862-9ECB-41B3-AE2F-536C0A2F2787Q38373676-3C45552C-EF19-4F91-B3A6-B510F5720774Q38477990-7DE1C3DD-2F81-4B5A-95A8-662CA6C9ED04Q38560197-A2C8E61E-6A22-4498-A057-8A52FBE8E458Q38571627-4BE796F6-E401-415B-B8B9-7D4D6BDAE7BDQ38878487-3DED06BA-E44F-48BC-860B-03E0BC08DAC9Q38933864-B21B686E-69F3-4291-9F01-07BDB7820D62Q39228463-0EB9F636-0AAE-496A-BCA6-249BE16A06F2Q39289642-316D11CD-3984-439C-A5FD-15D61FDC963AQ39407493-7E87103C-E198-4D9F-82AC-9EE9C29632A9Q39720738-86B98491-5C09-4FDE-A7B2-77690EEBCEC8Q42788492-6D5D4B29-9EDB-4F41-936E-D39F536B8889
P2860
Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Impact of implantable cardiove ...... death in heart failure trial.
@ast
Impact of implantable cardiove ...... death in heart failure trial.
@en
Impact of implantable cardiove ...... death in heart failure trial.
@nl
type
label
Impact of implantable cardiove ...... death in heart failure trial.
@ast
Impact of implantable cardiove ...... death in heart failure trial.
@en
Impact of implantable cardiove ...... death in heart failure trial.
@nl
prefLabel
Impact of implantable cardiove ...... death in heart failure trial.
@ast
Impact of implantable cardiove ...... death in heart failure trial.
@en
Impact of implantable cardiove ...... death in heart failure trial.
@nl
P2093
P2860
P50
P921
P1433
P1476
Impact of implantable cardiove ...... death in heart failure trial.
@en
P2093
Douglas L Packer
Freda Wood
George W Johnson
John P Boehmer
Jordan M Prutkin
Joseph G Rogers
L Brent Mitchell
Mark D Carlson
Mary Norine Walsh
Robert C Bernstein
P2860
P304
P356
10.1161/CIRCULATIONAHA.109.853689
P407
P577
2009-11-16T00:00:00Z